Bernd O. Evert

4.3k citations
49 papers · 3.3k indexed · 1 hit paper · h-index 30
Topics
Genetic Neurodegenerative Diseases (24 papers)Mitochondrial Function and Pathology (20 papers)Ubiquitin and proteasome pathways (9 papers)

In The Last Decade

Bernd O. Evert

48 papers receiving 3.2k citations

Hit Papers

Rapamycin alleviates toxicity of different aggregate-pron...20052026201220192005100200300400500

Peers

Bernd O. Evert
Comparison fields: 5 of 106
  • Molecular Biology 2.0k
  • Cellular and Molecular Neuroscience 1.3k
  • Physiology 588
  • Neurology 533
  • Epidemiology 448
Replace Tiziana Borsello with:
Tiziana Borsello Italy
Christoph Ullmer Switzerland
Irina G. Stavrovskaya United States
Santiago Ambrosio Spain
Yasuhide Mitsumoto Japan
Klaus Scholich Germany
Hélène Plun‐Favreau United Kingdom
Véronique Sazdovitch France
Yasushi Enokido Japan
Elena Alberdi Spain
Bernd O. Evert relative to Tiziana Borsello Italy Tiziana Borsello's profile →
Citations per field
00.5×1.5×2.0×
Tiziana Borsello · 1×
Citations per year

Countries citing papers authored by Bernd O. Evert

Since Specialization
Citations

This map shows the geographic impact of Bernd O. Evert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd O. Evert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd O. Evert more than expected).

Fields of papers citing papers by Bernd O. Evert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd O. Evert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd O. Evert. The network helps show where Bernd O. Evert may publish in the future.

Co-authorship network of co-authors of Bernd O. Evert

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd O. Evert. A scholar is included among the top collaborators of Bernd O. Evert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd O. Evert. Bernd O. Evert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 1
3 2
4 10
5 17
6 10
7 32
8 85
9 78
10 92
11 103
12 321
13 125
14 18
15 124
16 91
17
Rapamycin alleviates toxicity of different aggregate-prone proteinsbreakdown →
532
18 14
19 60
20 41

About Bernd O. Evert

Bernd O. Evert is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 49 papers that have together received 3.3k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (24 papers), Mitochondrial Function and Pathology (20 papers) and Ubiquitin and proteasome pathways (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.3k citations), Pharmacology (322 citations) and Neurology (533 citations). Bernd O. Evert has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Ullrich Wüllner, Thomas Klockgether, Ina Schmitt, Michel Eichelbaum, Péter Breuer, David C. Rubinsztein, Zdenek Berger, Brinda Ravikumar, Cahir J. O’Kane and Benjamin R. Underwood. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026